Skip to main content
Clinical Trials/ITMCTR2100005233
ITMCTR2100005233
Not Yet Recruiting
Phase 1

Clinical evaluation study of pricking blood therapy based on Xuanfu theory in the treatment of chronic urticaria

Hebei University of Chinese Medicine0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Hebei University of Chinese Medicine
Status
Not Yet Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Hebei University of Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\. Those who meet the diagnostic criteria of chronic urticaria in the EAACI/GA2LEN/EDF/WAO guidelines for the treatment of urticaria (2017\) and the Chinese guidelines for the treatment of urticaria (2018\);
  • 2\. Aged 18\-70 years;
  • 3\. No antihistamines use within 2 weeks before enrollment and no steroids or immunosuppressive drugs within 1 month;
  • 4\. The liver and kidney functions are normal;
  • 5\. Not participating in other ongoing clinical studies;
  • 6\. Voluntary participation and signed informed consent form.

Exclusion Criteria

  • 1\. Unconscious people who cannot express subjective symptoms of discomfort and psychiatric patients;
  • 2\. Those with Progressive malignant tumors or other serious wasting diseases, who are prone to co\-infection and bleeding;
  • 3\. Patients with severe primary diseases such as cardiovascular, liver, kidney, digestion, hematopoietic system;
  • 4\. Pregnant and lactating women.

Outcomes

Primary Outcomes

Not specified

Similar Trials